Targeting of CD19 By Tafasitamab Does Not Impair CD19...

Biology of Blood and Marrow Transplantation 2020 / 03 Vol. 26; Iss. 3

Targeting of CD19 By Tafasitamab Does Not Impair CD19 Directed Chimeric Antigen Receptor T Cell Activity in Vitro

Horvei, Paulina, Sakemura, Reona, Cox, Michelle J., Roman, Claudia Manriquez, Schick, Kendall J., Ruff, Michael W., Hefazi, Mehrdad, Tapper, Erin E., Hansen, Michael J., Schanzer, Jürgen, Endell, Jan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2019.12.201
Date:
March, 2020
File:
PDF, 78 KB
2020
Conversion to is in progress
Conversion to is failed